Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   HEPATITIS MONTHLY   2016 , Volume 16 , Number 4; Page(s) 0 To 0.
 
Paper: 

HEPATITIS B VIRUS INFECTION IN THE GENERAL POPULATION OF IRAN: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS

 
 
Author(s):  SALEHI VAZIRI MOSTAFA, SADEGHI FARZIN, ALMASI HASHIANI AMIR, GHOLAMI FESHARAKI MOHAMMAD, ALAVIAN SEYED MOAYED*
 
* BAQIYATALLAH RESEARCH CENTER FOR GASTROENTEROLOGY AND LIVER DISEASES, BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES TEHRAN, IR IRAN
 
Abstract: 

Context: The hepatitis B virus (HBV) is a major global public health problem, affecting more than 2 billion people worldwide. Accurate and updated data on HBV prevalence is important for further planning to control the infection. The aim of this study was to update the prevalence estimate of HBV infection in the general population of Iran.
Evidence Acquisition: A systematic review was done for data on the prevalence of HBV infection in the general Iranian population published between Jan.1, 1990, and Jan.1, 2016, in both international and national databases, including PubMed, Scopus, Web of Science, Scientific Information Database, Iran Medex, and Magiran. All papers with clearly described time and location of the study, proper sampling strategies, and proper analysis methods were included in the present study. Data were extracted by two independent reviewers. Prevalence of HBV infection with a 95% confidence interval (CI) was calculated using Stata software, version 13.
Results: The polled estimated prevalence of HBV infection in the general population of Iranwas2.2% (95% CI: 1.9% - 2.6%). The highest prevalence of HBV infection (8.9%, 95% CI: 7.6% - 10.2%) was reported from Golestan province, and the lowest prevalence (0.7%, 95% CI: 0.4% - 1.1%) was seen in Kermanshah province. The prevalence of HBV infection was estimated at 3% (95% CI: 2.2% - 3.8%) for Iranian males and 1.7% (95% CI: 1.2% - 2.3%) for Iranian females. The prevalence of HBV infection in the general population of Iran was 2.9% (95% CI: 2.5% - 3.4%) before 2010 and 1.3% (95% CI: 0.9% - 1.7%) after 2010.
Conclusions: In total, Iran was classified within the low–intermediate HBV prevalence areas (2% - 4%), while according to recent data (after 2010), Iran was classified within the low HBV prevalence areas (<2%), indicating that preventive measures conducted in Iran have been effective.

 
Keyword(s): HEPATITIS B VIRUS, IRAN, META-ANALYSIS, PREVALENCE
 
 
References: 
 
Citations: 
 
+ Click to Cite.
APA: Copy

SALEHI VAZIRI, M., & SADEGHI, F., & ALMASI HASHIANI, A., & GHOLAMI FESHARAKI, M., & ALAVIAN, S. (2016). HEPATITIS B VIRUS INFECTION IN THE GENERAL POPULATION OF IRAN: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS. HEPATITIS MONTHLY, 16(4), 0-0. https://www.sid.ir/en/journal/ViewPaper.aspx?id=510569



Vancouver: Copy

SALEHI VAZIRI MOSTAFA, SADEGHI FARZIN, ALMASI HASHIANI AMIR, GHOLAMI FESHARAKI MOHAMMAD, ALAVIAN SEYED MOAYED. HEPATITIS B VIRUS INFECTION IN THE GENERAL POPULATION OF IRAN: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS. HEPATITIS MONTHLY. 2016 [cited 2021July31];16(4):0-0. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=510569



IEEE: Copy

SALEHI VAZIRI, M., SADEGHI, F., ALMASI HASHIANI, A., GHOLAMI FESHARAKI, M., ALAVIAN, S., 2016. HEPATITIS B VIRUS INFECTION IN THE GENERAL POPULATION OF IRAN: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS. HEPATITIS MONTHLY, [online] 16(4), pp.0-0. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=510569.



 
  pdf-File
Yearly Visit 86
 
 
Latest on Blog
Enter SID Blog